Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan;33(1):6-8.
doi: 10.1681/ASN.2021111471.

Disarming the Old Foe. Restoring T-Cell Immune Function with mTor-Inhibitors to Tackle Cytomegalovirus Infection

Oriol Bestard  1 , Elena Crespo
Affiliations
Editorial

Disarming the Old Foe. Restoring T-Cell Immune Function with mTor-Inhibitors to Tackle Cytomegalovirus Infection

Oriol Bestard et al. J Am Soc Nephrol. 2022 Jan.
No abstract available

Keywords: cytomegalovirus; immunology and pathology; kidney transplantation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Immunomodulation of mTor-inhibitors promoting the restoration of a functional immune profile on memory CD8+ αβ T cells and Vδ2neg γδ T cells enabling CMV viral control. CMV, cytomegalovirus; mTor-I, mammalian target of rapamycin inhibitors; NK T cells, natural killer cells; R+, CMV IgG serological positive transplant recipients.
See this image and copyright information in PMC

Comment on

References

    1. Raval AD, Kistler KD, Tang Y, Murata Y, Snydman DR: Epidemiology, risk factors, and outcomes associated with cytomegalovirus in adult kidney transplant recipients: A systematic literature review of real-world evidence. Transpl Infect Dis 23: e13483, 2021 - PubMed
    1. Berry R, Watson GM, Jonjic S, Degli-Esposti MA, Rossjohn J: Modulation of innate and adaptive immunity by cytomegaloviruses. Nat Rev Immunol 20: 113–127, 2020 - PubMed
    1. Jarque M, Crespo E, Melilli E, Gutiérrez A, Moreso F, Guirado L, et al. : Cellular Immunity to Predict the Risk of Cytomegalovirus Infection in Kidney Transplantation: A Prospective, Interventional, Multicenter Clinical Trial. Clin Infect Dis 71: 2375–2385, 2020 - PubMed
    1. Kumar D, Mian M, Singer L, Humar A: An Interventional Study Using Cell-Mediated Immunity to Personalize Therapy for Cytomegalovirus Infection After Transplantation. Am J Transplant 17: 2468–2473, 2017 - PubMed
    1. Couzi L, Pitard V, Moreau JF, Merville P, Déchanet-Merville J: Direct and indirect effects of cytomegalovirus-induced γδ T cells after kidney transplantation. Front Immunol 6: 3, 2015. 10.3389/fimmu.2015.00003 - DOI - PMC - PubMed